PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses

References

• RosenbergSAProgress in human tumour immunology and immunotherapyNature2001411683538038411357146
   PubMed Web of Science ®Google Scholar
• SloanJMKershawMHTouloukianCEMHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsCancer Gene Ther200291194695012386833
   PubMed Web of Science ®Google Scholar
• SteinmanRMLasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune systemNat Med200713101155115917917664
   PubMed Web of Science ®Google Scholar
• EpaulardOToussaintBQueneeLAnti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vectorMol Ther200614565666117010670
   PubMed Web of Science ®Google Scholar
• MurthyNCampbellJFaustoNHoffmanASStaytonPSBioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugsBioconjug Chem200314241241912643752
   PubMed Web of Science ®Google Scholar
• SpiesTCerundoloVColonnaMCresswellPTownsendADeMarsRPresentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimerNature199235563616446461538752
   PubMed Web of Science ®Google Scholar
• LehnerPJCresswellPProcessing and delivery of peptides presented by MHC class I moleculesCurr Opin Immunol19968159678729447
   PubMed Web of Science ®Google Scholar
• RosenbergSAYangJCRestifoNPCancer immunotherapy: moving beyond current vaccinesNat Med200410990991515340416
   PubMed Web of Science ®Google Scholar
• NoguchiMMineTKomatsuNAssessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccinationCancer Biol Ther201110121266127920935522
   PubMed Web of Science ®Google Scholar
• BrunsvigPFKyteJAKerstenCTelomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trialClin Cancer Res201117216847685721918169
   PubMed Web of Science ®Google Scholar
• GreenlandJRLetvinNLChemical adjuvants for plasmid DNA vaccinesVaccine200725193731374117350735
   PubMed Web of Science ®Google Scholar
• DobrovolskaiaMAMcNeilSEImmunological properties of engineered nanomaterialsNat Nanotechnol20072846947818654343
   PubMed Web of Science ®Google Scholar
• SahooSKMaWLabhasetwarVEfficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancerInt J Cancer2004112233534015352049
   PubMed Web of Science ®Google Scholar
• YamamotoHKunoYSugimotoSTakeuchiHKawashimaYSurface- modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctionsJ Control Release2005102237338115653158
   PubMed Web of Science ®Google Scholar
• ZhangNChittasuphoCDuangratCSiahaanTJBerklandCPLGA nanoparticle–peptide conjugate effectively targets intercellular cell-adhesion molecule-1Bioconjug Chem200819114515217997512
   PubMed Web of Science ®Google Scholar
• CampolongoMJLuoDDrug delivery: old polymer learns new tractsNat Mater20098644744819458640
   PubMed Web of Science ®Google Scholar
• PrabhaSLabhasetwarVNanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cellsMol Pharm20041321121915981924
   PubMed Web of Science ®Google Scholar
• PrabhaSZhouWZPanyamJLabhasetwarVSize-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticlesInt J Pharm20022441–210511512204570
   PubMed Web of Science ®Google Scholar
• PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J200216101217122612153989
   PubMed Web of Science ®Google Scholar
• VasirJKLabhasetwarVTargeted drug delivery in cancer therapyTechnol Cancer Res Treat20054436337416029056
   PubMed Web of Science ®Google Scholar
• MaWSmithTBoginVEnhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapyJ Transl Med201193421450109
   PubMed Web of Science ®Google Scholar
• MinevBHippJFiratHSchmidtJDLanglade-DemoyenPZanettiMCytotoxic T cell immunity against telomerase reverse transcriptase in humansProc Natl Acad Sci U S A20009794796480110759561
   PubMed Web of Science ®Google Scholar
• de VriesIJLesterhuisWJBarentszJOMagnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapyNat Biotechnol200523111407141316258544
   PubMed Web of Science ®Google Scholar
• MailliardRBEgawaSCaiQComplementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responsesJ Exp Med2002195447348311854360
   PubMed Web of Science ®Google Scholar
• CraiuAAkopianTGoldbergARockKLTwo distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptideProc Natl Acad Sci U S A1997942010850108559380723
   PubMed Web of Science ®Google Scholar
• de Garcia-HernandezMLGrayAHubbyBKastWMIn vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancerCancer Res20076731344135117283172
   PubMed Web of Science ®Google Scholar
• MaWYuHWangQJinHSolheimJLabhasetwarVA novel approach for cancer immunotherapy: tumor cells with anchored superantigen SEA generate effective antitumor immunityJ Clin Immunol200424329430115114060
   PubMed Web of Science ®Google Scholar
• YangDHoltGEVeldersMPKwonEDKastWMMurine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate miceCancer Res200161155857586011479226
   PubMed Web of Science ®Google Scholar
• ItoFFujimoriHMakinoKFactors affecting the loading efficiency of water-soluble drugs in PLGA microspheresColloids Surf B Biointerfaces2008611252917719753
   PubMed Web of Science ®Google Scholar
• RosenbergSAKawakamiYRobbinsPFWangRIdentification of the genes encoding cancer antigens: implications for cancer immunotherapyAdv Cancer Res1996701451778902056
   PubMed Web of Science ®Google Scholar
• RewSBPeggsKSanjuanIGeneration of potent antitumor CTL from patients with multiple myeloma directed against HM1.24Clin Cancer Res20051193377338415867238
   PubMed Web of Science ®Google Scholar
• XiangSDScalzo-InguantiKMinigoGParkAHardyCLPlebanskiMPromising particle-based vaccines in cancer therapyExpert Rev Vaccines2008771103111918767957
   PubMed Web of Science ®Google Scholar
• MandelboimOVadaiEFridkinMRegression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptidesNat Med1995111117911837584991
   PubMed Web of Science ®Google Scholar
• MesaCFernandezLEChallenges facing adjuvants for cancer immunotherapyImmunol Cell Biol200482664465015550123
   PubMed Web of Science ®Google Scholar
• SinghMO’HaganDAdvances in vaccine adjuvantsNat Biotechnol199917111075108110545912
   PubMed Web of Science ®Google Scholar
• FifisTGamvrellisACrimeen-IrwinBSize-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumorsJ Immunol200417353148315415322175
   PubMed Web of Science ®Google Scholar
• YadavKSChuttaniKMishraAKSawantKKEffect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA NanoparticlesPDA J Pharm Sci Technol201165213113921502074
   PubMedGoogle Scholar
• LiSDHuangLNanoparticles evading the reticuloendothelial system: role of the supported bilayerBiochim Biophys Acta20091788102259226619595666
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
   PubMed Web of Science ®Google Scholar
• TsaiYMChienCFLinLCTsaiTHCurcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetrationInt J Pharm2011416133133821729743
   PubMed Web of Science ®Google Scholar
• GuFZhangLTeplyBAPrecise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProc Natl Acad Sci U S A200810572586259118272481
   PubMed Web of Science ®Google Scholar
• DharSGuFXLangerRFarokhzadOCLippardSJTargeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticlesProc Natl Acad Sci U S A200810545173561736118978032
   PubMed Web of Science ®Google Scholar
• BennyOMenonLGArielGLocal delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growthClin Cancer Res20091541222123119190128
   PubMed Web of Science ®Google Scholar
• Kaiser-SchulzGHeitAQuintanilla-MartinezLPolylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responsesJ Immunol200717952797280717709493
   PubMed Web of Science ®Google Scholar
• WangXWenkEHuXSilk coatings on PLGA and alginate microspheres for protein deliveryBiomaterials200728284161416917583788
   PubMed Web of Science ®Google Scholar
• TseMTBlatchfordCOya AlparHEvaluation of different buffers on plasmid DNA encapsulation into PLGA microparticlesInt J Pharm20093701–2334019059325
   PubMed Web of Science ®Google Scholar
• PeartonMAllenderCBrainKGene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulationsPharm Res200825240741617671832
   PubMed Web of Science ®Google Scholar
• JesselNOulad-AbdelghaniMMeyerFMultiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayerProc Natl Acad Sci U S A2006103238618862116735471
   PubMed Web of Science ®Google Scholar
• CholerisELittleSRMongJAPuramSVLangerRPfaffDWMicroparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female miceProc Natl Acad Sci U S A2007104114670467517360582
   PubMed Web of Science ®Google Scholar
• SirsiSRSchrayRCWheatleyMALutzGJFormulation of poly-lactide- co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotidesJ Nanobiotechnology200971119351396
   PubMedGoogle Scholar
• GoforthRSalemAKZhuXImmune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanomaCancer Immunol Immunother200958451753018719913
   PubMed Web of Science ®Google Scholar
• ElamanchiliPDiwanMCaoMSamuelJCharacterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cellsVaccine200422192406241215193402
   PubMed Web of Science ®Google Scholar
• LutsiakMEKwonGSSamuelJBiodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responsesJ Pharm Pharmacol200658673974716734975
   PubMed Web of Science ®Google Scholar
• HamdySMolaviOMaZCo-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunityVaccine200826395046505718680779
   PubMed Web of Science ®Google Scholar
• NewmanKDSamuelJKwonGOvalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune responseJ Control Release199854149599741903
   PubMed Web of Science ®Google Scholar
• DiwanMElamanchiliPLaneHGainerASamuelJBiodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responsesJ Drug Target2003118–1049550715203918
   PubMed Web of Science ®Google Scholar